Literature DB >> 2917920

Cardiovascular failure and apnea in shock.

S Nava1, F Bellemare.   

Abstract

A model of shock was developed in anesthetized dogs by limiting venous return with a balloon inflated in the right atrium. The change in ventilation (VE) in response to a sustained decrease in arterial pressure (Pa) to 50-60 Torr was studied by recording transdiaphragmatic pressure (Pdi) and diaphragm (Edi) and parasternal intercostal (Eic) electrical activity. Four dogs died of cardiac arrest after 20-60 min. In 11 dogs, VE, after an initial increase, decreased progressively until apnea occurred after 103 +/- 24 min, after 60% reductions in breathing frequency, Pdi, and Eic and a 30% fall in Edi. No decrease in diaphragm contractility was found in response to artificial phrenic nerve stimulation. The cardiocirculatory function deteriorated during shock until it became irreversible at apneic time. No recovery from apnea occurred without a recovery of Pa. We conclude that the fall in VE and ensuing apnea in this model resulted from a decrease in central respiratory neural output associated with a progressive deterioration of the cardiocirculatory function.

Entities:  

Mesh:

Year:  1989        PMID: 2917920     DOI: 10.1152/jappl.1989.66.1.184

Source DB:  PubMed          Journal:  J Appl Physiol (1985)        ISSN: 0161-7567


  3 in total

1.  Respiratory recovery following organophosphate poisoning in a rat model is suppressed by isolated hypoxia at the point of apnea.

Authors:  Romolo J Gaspari; David Paydarfar
Journal:  Toxicology       Date:  2012-08-18       Impact factor: 4.221

2.  Respiratory muscle injury, fatigue and serum skeletal troponin I in rat.

Authors:  Jeremy A Simpson; Jennifer Van Eyk; Steve Iscoe
Journal:  J Physiol       Date:  2003-12-12       Impact factor: 5.182

3.  Cerebral cortex and respiratory muscles perfusion during spontaneous breathing attempts in ventilated patients and its relation to weaning outcomes: a protocol for a prospective observational study.

Authors:  Daniel Langer; Greet Hermans; Zafeiris Louvaris; Marine Van Hollebeke; Alexander Dhaenens; Maarten Vanhemelen; Philippe Meersseman; Joost Wauters; Rik Gosselink; Alexander Wilmer
Journal:  BMJ Open       Date:  2019-10-31       Impact factor: 2.692

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.